1,237
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Biomarker Revolution: A Step Toward Personalized Medicine

Pages 553-556 | Published online: 10 Nov 2008

Bibliography

  • Biomarker Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69(3) , 89–95 (2001).
  • De Gruttola VG , ClaxP, DeMetsDL et al.: Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.Control. Clin. Trials22(5) , 485–502 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.